|
HS Code |
864446 |
| Generic Name | Homatropine Hydrobromide |
| Drug Class | Anticholinergic (Mydriatic/Cycloplegic) |
| Chemical Formula | C16H21NO3·HBr |
| Route Of Administration | Ophthalmic (eye drops) |
| Main Uses | Dilation of pupil, cycloplegia for eye examinations |
| Mechanism Of Action | Blocks muscarinic receptors, inhibiting acetylcholine in the eye |
| Onset Of Action | Typically within 10-30 minutes |
| Duration Of Action | Lasts 1-3 days |
| Contraindications | Narrow-angle glaucoma, hypersensitivity to homatropine |
| Side Effects | Blurred vision, photophobia, increased intraocular pressure, dry mouth |
As an accredited Homatropine Hydrobromide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle with child-resistant cap, labeled “Homatropine Hydrobromide 10 mg tablets, 100 count.” Includes manufacturer info and dosage instructions. |
| Shipping | Homatropine Hydrobromide is shipped in tightly sealed, light-resistant containers to prevent degradation. It should be packed to avoid moisture and contamination, with clear hazard labeling as a pharmaceutical chemical. Shipping follows regulatory guidelines for controlled substances, usually under ambient conditions, with supporting documentation for safe and compliant handling during transport. |
| Storage | Homatropine Hydrobromide should be stored in a well-closed container at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F). Protect it from light, moisture, and excessive heat. Keep away from incompatible substances and ensure the storage area is secure, clean, and designated for pharmaceuticals to prevent contamination or accidental misuse. |
Applications of Homatropine Hydrobromide in Industrial ManufacturingHomatropine hydrobromide serves as a vital raw material in selected pharmaceutical synthesis and processing environments. Our manufacturing experience supports its deployment in regulated fields, facilitating precise control over chemical integration and compliance with industry standards. Below, we outline its principal downstream uses with reference to regulatory requirements, common usage quantities, stage of process incorporation, and expected finished goods. 1. Ophthalmic Formulation ManufacturingOphthalmic solution manufacturers rely on homatropine hydrobromide as an antimuscarinic agent for pupil dilation and ciliary muscle paralysis prior to diagnostic procedures. Quality control procedures govern its use in sterile eye drop preparations. Pharmacopoeial specifications determine purity, microbial limits, and particle size during blending. Manufacturers measure ingredient proportions based on prescribed pharmacological effect, adjusting for patient sensitivity profiles and product concentration targets. Product batches run through repeated filtration and sterile filling to safeguard end-use safety. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Injectable Anticholinergic Drug ProductionSterile injectable manufacturers include this ingredient as an alkaloid anticholinergic component for acute preoperative or diagnostic use. Accurate dosing depends on solubility studies and compatibility checks with carrier solvents. Batch records include validated mixing times and in-process analytical verification for impurity thresholds. Regulatory authorities demand batch traceability, sterility assurances, and consistent potency levels in the injectable manufacturing workflow. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Bulk Pharmaceutical Ingredient (BPI) Supply for Finished Dosage ProcessingAPI contract manufacturers supply homatropine hydrobromide in bulk grade to facilities that produce final pharmaceutical tablets and oral liquids. Production teams ensure compliance with API-specific Good Manufacturing Practices and comprehensive impurity profiling before shipment. Clients audit analytical data and request customized particle sizes or moisture levels for efficient downstream blending. Each lot receives a Certificate of Analysis and must pass retesting upon arrival at the final formulator premises, especially for global regulatory markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Reference Standard Preparation in Analytical LaboratoriesQuality control and research laboratories acquire certified homatropine hydrobromide as a reference substance for calibration and method validation in pharmaceutical product testing. Standards issued in defined purity percentages support HPLC, titration, and spectrophotometric quantitation procedures. Scientists maintain traceability against international reference materials for compliance assessment, typically under controlled environmental conditions. Laboratories follow protocols to check retention times, peak area responses, and linearity using matrix-matched standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Homatropine Hydrobromide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Daily work in the chemical manufacturing industry revolves around attention to raw material quality and the discipline of repeatable, scalable processes. Over the years, the landscape around pharmaceutical intermediates and active ingredients has grown more rigorous. Our plant’s experience with Homatropine Hydrobromide stretches back decades. This product, produced under tight regulatory conditions, fits a distinct niche in ophthalmology.
Every batch reflects the standards demanded by pharmaceutical end-users. From the selection of the base tropine alkaloid to the control of hydrobromic acid addition, small variables can introduce differences that affect every downstream application. We monitor each step with high-performance liquid chromatography, not just for purity but for stability over its intended shelf life. Teams in our facility know that even subtle impurities alter the performance physicians and patients rely on.
This compound enters the medical toolkit where pupil dilation, cycloplegic effects, and reduced ocular discomfort are needed. Our production process goes beyond the requirements for bulk chemicals. We build every lot under controlled temperature environments, followed by a multi-stage recrystallization that gives the finished material consistent granulation and reactivity when compounded into finished dosage forms.
Homatropine Hydrobromide proves especially valuable in clinical settings because it provides shorter durations of action compared to its relatives, such as atropine sulfate. This pharmacological window matters for pediatric and adult eye exams alike. Optometrists and ophthalmologists prefer a compound they know will produce reliable mydriasis and cycloplegia without keeping the patient under blurred vision for too long. It is no exaggeration to say that in many countries, reliable homatropine determines how practitioners deliver quality eye care.
In chemical manufacturing, quality benchmarks serve as a guardrail against deviation. Homatropine Hydrobromide, delivered as a white to near-white crystalline powder, is produced to exceed compendial standards. Assay levels run above 99% on a dry basis. Moisture thresholds are held below 0.5%. In-process controls ensure that related substances do not rise above tight limits, since even trace levels complicate formulation or regulatory filings.
Particle size control is another area where our facility’s knowledge gives us an advantage. Ophthalmic excipients—especially in sterile settings—demand a predictable range. Our teams operate specialized dryers and screeners to deliver a uniform mesh size that blends well with any intended vehicle. Whether the shipment is destined for bulk solution or smaller compounding use, it arrives as requested. Each drum or package comes with a full certificate of analysis, backed by traceable batch records.
The pharmaceutical world doesn’t lack for similar agents. Atropine, cyclopentolate, and tropicamide sit near Homatropine Hydrobromide on the chemical family tree. Differences are more than academic. Slight variations in their side chains and salt forms dictate how long they act, how fast they take effect, and their risk of off-target effects. Atropine extends mydriatic action well beyond twenty-four hours in many cases, while homatropine produces a more manageable window of four to eight hours. For patient convenience and adherence, this often distinguishes which agent practitioners reach for in non-urgent cases.
The chemical backbone—tropine—gives this class of alkaloids their antimuscarinic effect. Our synthesis keeps side-reactions in check, eliminating formation of unwanted by-products like apoatropine or tropine esters. Each variant serves a particular therapeutic need, but not all deliver identical handling in manufacturing or compounding. Our years of process adjustment and feedback from end-users has honed a product that performs reliably in suspensions and solutions.
The regulatory game changed a long time ago. Agencies ask for data transparency, not just an end certificate. Our internal controls produce full validation documentation, including cleaning procedures, method validations, and cross-contamination studies. Many customers operate in advanced regulatory environments where documentation quality ranks as high as material quality. Drug master files and complete traceability aren't optional add-ons—they are the starting point.
Each batch of Homatropine Hydrobromide produced in our plant can trace its raw materials, operator signatures, and analytical records. We routinely host audits, both virtual and in-person, and share all process validation and supplier qualification materials. Trust, after all, builds slowly. Delivering on technical expectations and backing it up with careful record-keeping ensures quality extends beyond buzzwords.
A great deal of experience goes into refining the synthesis route for Homatropine Hydrobromide. The process starts with the careful purification of homatropine, itself a derivative of mandelic acid esterified to tropine. Our chemists know how slight over-reaction or residual solvents show up in the spectral analysis. Each tank load gets monitored by GC and NMR, not just at the end but at critical points in the process.
Adding hydrobromic acid appears simple on paper, but in practice, it calls for temperature and flow monitoring to stave off side-reactions. Uncontrolled conditions result in off-color impurities, a headache for those tasked with downstream sterilization and solution clarity. Our experience has shown that optimizing cooling rates, agitation speed, and pH targets keeps those impurities where they belong—out of the finished drum. The process design includes steps for active charcoal treatment and fine filtration that remove even sub-visible particles. No one wants to open a drum and find unexpected specks or an off-shade powder.
The reliability of a pharmaceutical ingredient trickles down to the point of care. Homatropine Hydrobromide reaches clinics and hospitals where time and predictability matter. Patients, many of them children or elderly, depend on a routine procedure like a dilated eye exam to go smoothly. Material inconsistencies—cloudiness, poor solubility, or unpredictable onset—force practitioners to reschedule, waste prepared solutions, or expose patients to longer-acting alternatives.
True quality isn’t just analytical paperwork. Batch after batch must dissolve as expected and deliver consistent patient outcomes. Eye care professionals aren’t looking for surprises. They measure impact in terms of patient comfort, appointment time, and post-procedure satisfaction. A manufacturer can rest on a reputation only if every order matches those expectations, without drift or exception.
The chemical industry faces ongoing pressure to minimize waste and adopt smarter resource management. We’ve invested in closed-loop solvent recovery, energy-efficient drying, and advanced air-handling systems that reduce process loss. Handling hydrobromic acid in bulk has always posed safety and environmental risks. We carry out regular staff training and real-time monitoring to limit emissions. Our site works with local authorities on hazardous waste handling, recycling, and spill prevention.
For manufacturers like us, balancing environmental duty and consistent product output is a constant process. Our waste minimization plan goes beyond compliance. Any off-specification material gets landfilled only as a last resort. Solvent streams run through fractional distillation columns to maximize reuse, not just slash disposal expense but ensure a tighter control over trace contamination that creeps in with “fresh” purchased solvents.
Feedback shapes how we manufacture Homatropine Hydrobromide today. Customers—some with decades-long relationships—provide direct insight about what works and what doesn’t at the point of compounding. We’ve made technical adjustments over time to reduce static charge during transfer, prevent clumping in humid climates, and improve packaging liners to cut down on powder loss.
Sterility in ophthalmic compounding can't tolerate packaging flaws. Based on industry input, we moved to pharmaceutical-grade liners and inert gas flushing. These improvements don’t stem from a desire to stand out for marketing’s sake. They solve real-world problems that arise in handling and preparation. Customers notice when a product changes, even subtly. That calls for transparency, documented change controls, and a willingness to revert any “improvement” if it doesn’t land well.
Medication choice matters when it involves the eyes. The burden of side effects, patient anxiety, and the logistical headache of prolonged pupil dilation all factor into product selection. Homatropine Hydrobromide’s shorter acting time helps clinics move patients through exam protocols efficiently while reducing treatment burden. More than that, it narrows the anxiety patients feel about returning to normal activities after visiting the ophthalmologist.
For systemic safety, the peripheral antimuscarinic effects of homatropine trend lower than those of atropine, which allows for less risk in the hands of experienced prescribers. Physicians know exactly how long the compound will act, and patient education becomes more straightforward. The compound provides strong mydriasis and cycloplegia at dosages that avoid the pitfall of excessive lingering effect.
Running a chemical plant that meets the needs of pharmaceutical end-users takes more than a catalog and a certificate. Process improvement calls for eyes on the line. Teams check not just for compliance, but for what could go wrong: condensation forming on the packaging during storage, minor shifts in mesh size that change how well the powder dissolves, or small upticks in trace impurities that creep in with a new lot of raw material.
Our technicians don’t wait for customer complaints to spot drift. In-line analytical equipment gives real-time feedback, and every operator has the authority to pull product that doesn’t meet spec. This mindset, learned over many years and shaped by real-world consequences, forms the backbone of why our Homatropine Hydrobromide keeps up with the strategic patience expected by manufacturers of sterile and near-sterile formulations.
A real strength in manufacturing comes not from owning the latest equipment, but from managing every link in the supply chain. Our facility sources raw alkaloid from vetted agriculture partners, with annual audits of their extraction methods and post-harvest handling. Every drum of precursor material ships with its own analytical profile. We do not release a final product without reconciling the raw material’s input with process yields and finished quality.
On-site stability chambers track every lot for shelf life in both high and low humidity settings, at room temperature and under refrigeration. Reports feed directly into our shipping recommendations. Customers who routinely store raw ingredients in less-than-ideal conditions depend on this data to avoid surprises at the point of compounding.
The market for ophthalmic pharmaceuticals keeps evolving. Shifting guidelines, new warnings on excipients, or changes in allowable impurity thresholds mean that a manufacturing process cannot stand still. Our team attends industry symposia, works with pharmacopoeia groups, and readings of newly published draft guidance shape our own internal protocols long before official enforcement begins.
Staying ahead often calls for investing in new detection equipment, updating analytical method validations, or qualifying alternative excipient suppliers to keep the whole process nimble. Our plant’s flexibility grew from past experience navigating sudden regulatory changes, such as restrictions on certain organic solvents or demands for lower heavy metal content in finished goods. We keep technical staff updated with continuous training so that answers to regulatory questions flow quickly.
Though customers expect certificates and documentation, what keeps them coming back is consistency. Quality means much more to them than paper assurances. Customers expect the same performance year after year and trust that we alert them to any changes—voluntary or imposed—before those changes show up at their facility.
As a manufacturer, we enter a long-term relationship with every customer, clinical or industrial. The product batches consumed today reflect decisions and improvements made years earlier. Open feedback channels, site visits, technical data sharing, and a clear escalation process serve as the foundation for those relationships. No marketing can substitute for a phone call at the right moment or a willingness to rush a batch if timelines suddenly change.
Sustaining trust in the quality and reliability of Homatropine Hydrobromide takes work beyond daily operations. Regulatory agencies expect an evolving risk assessment. Customers want innovations that enhance patient experience and simplify workflow. Investments in green chemistry, digital monitoring, and automated analysis aren’t just trends—they are necessities.
We see our role as a partner to innovators who shape the future of vision care. Whether it’s improving solubility profiles, supplying smaller lots for advanced compounding, or adapting to new sterilization protocols, we keep a close watch on the shifting needs of the field. Years of manufacturing have taught us that change rarely stands still for long. By learning from every lot, every customer conversation, and every regulatory inspection, we commit daily to keeping Homatropine Hydrobromide at the highest standard of availability and performance in ophthalmic care.